Eurofins Biomnis code

VIMPA

Specialty

Analytical Chemistry

Clinical significance

Lacosamide is an antileptic treatment used alone or in combination to treat partial and generalised seizures. It acts on sodium channels to stabilise neuronal activity.

Preanalytics

• 1 x 1 mL :
• Serum (do not use tubes with separator gel)
•   FROZEN
• Freezing within 4 hours

• A tube specifically for this analysis : Yes

Further information

Enclose the specific clinical information form (R13-INTGB : Medication quantification)
The therapeutic drug monitoring code suggests that the sample should be carried out at the residual rate (just before taking medication).
1 individual aliquot for this analysis.
The following tests can be performed on the same sample: Levetiracetam; Gabapentin; Lamotrigine; Oxacarbazepine/10-OH-Carbazepine; Topiramate; Lacosamide

Documents to download

• Specific clinical information form (R13-INTGB)

Methodology

LCMS/MS

Turnaround time

4 days